MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • MDS Virtual Congress 2021

    A Double Blind, Placebo Controlled, Crossover Study of Incobotulinumtoxin-A in Musician’s Focal Hand Dystonia

    S. Frucht, A. Nmashie, MC. George, C. Wu, A. Pantelyat, E. Altenmüller, M. Chen, D. Feng, DM. Simpson (New York, USA)

    Objective: To determine the safety and efficacy of incobotulinumtoxin-A (BoNT) in musician’s dystonia. Background: Few published trials of BoNT in upper limb task-specific dystonia are…
  • MDS Virtual Congress 2021

    Treatment of cervical dystonia using shorter incobotulinumtoxinA injection intervals improves patient-reported outcomes in those with inadequate benefits from standard intervals

    S. Isaacson, D. Charles, C. Comella, D. Truong, O. Oguh, J. Hui, E. Molho, M. Brodsky, E. Furr-Stimming, G. Comes, M. Hast, R. Hauser (Boca Raton, USA)

    Objective: To assess the impact of 2 different injection schedules of incobotulinumtoxinA on patient-reported assessments in cervical dystonia (CD). Background: There is individual variation in…
  • MDS Virtual Congress 2021

    A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia

    J. Jankovic, C. Comella, R. Hauser, A. Patel, T. Gross, R. Rubio, D. Vitarella (Houston, USA)

    Objective: To evaluate the efficacy and safety of two doses of DaxibotulinumtoxinA for Injection (DAXI) vs placebo for treatment of cervical dystonia (CD). Background: DAXI…
  • MDS Virtual Congress 2021

    Current perspectives on the management of cervical dystonia among global clinicians

    H. Jinnah, H. Ferraz, S. Standal, P. Fattahi, A. Zuzek, N. Alibhai, K. Merath (Atlanta, USA)

    Objective: The aim of this study was to gain the perspectives of clinicians who treat patients with CD in terms of assessment and treatment goals,…
  • MDS Virtual Congress 2021

    The main reasons for essential blepharospasm botulinum neurotoxin (BoNT) treatment discontinuation in Latvian population.

    K. Lazdovska, R. Valante (Riga, Latvia)

    Objective: To investigate the effectiveness of BoNT treatment in patients with essential blepharospasm and determine the most common reasons for discontinuation of the treatment. Background: Essential…
  • MDS Virtual Congress 2021

    Does Microneedle Use for Facial Injection of Botulinum Toxin Reduce Pain? A Systematic Literature Review

    S. Maytharakcheep (Bangkok, Thailand)

    Objective: To perform a systematic review to identify relevant literature on pain outcomes after injecting BTX with a microneedle for various facial conditions and to…
  • MDS Virtual Congress 2020

    Smell and Taste in Blepharospasm

    J. Gamain, T. Herr, T. Hummel, B. Veit, C. Willert, B. Lehnert, R. Fleischmann, A. Stenner, F. Tost, M. Kronenbürger (Greifswald, Germany)

    Objective: To contribute to the better understanding of blepharospasm, we systematically assess olfactory and gustatory ability in subjects with blepharospasm, compared to subjects with cervical…
  • MDS Virtual Congress 2020

    Writer’s cramp: A focal dystonia exacerbated by psychological symptoms

    A. Verghese (Georgetown, Malaysia)

    Objective: Here we retrospectively analysed nineteen patients followed up in our centre, the Neurology Unit of the Penang General Hospital, for writer’s cramp from the…
  • MDS Virtual Congress 2020

    Management of Cervical Dystonia & Spastic Paresis with Botulinum Neurotoxin-A: results from the INPUT survey

    R. Bhidayasiri, L.J Jacinto, K. Bhatia, N. Dursun, T.M Chung, J. Tiley, C. Colosimo (Bangkok, Thailand)

    Objective: To describe current practices among physicians using botulinum toxin-A (BoNT-A) to treat spastic paresis (SP) and cervical dystonia (CD). Background: BoNT-A is an effective…
  • MDS Virtual Congress 2020

    Effects of onabotulinum toxin A on balance and gait in Parkinson’s disease with foot dystonia: A case series study

    P. Huang, YY. Li, P. Huang, Q. Xiao, Y. Wang, S. Chen, S.D Chen, J. Liu, Y.W Wu (Shanghai, China)

    Objective: To investigate the effectiveness of botulinum toxin (BoNT) in reducing the severity of dystonia and improving gait and balance in Parkinson’s disease (PD) patients…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Carpal Tunnel Syndrome in Patients with Tremor
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley